Work

Op0241 Safety and Efficacy of Lenabasum in an Open-label Extension of a Phase 2 Study of Lenabasum in Refractory Skin-predominant Dermatomyositis (dm) Subjects

Year: 2019

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2019-eular.3397

Authors: Victoria Werth, David Pearson, Joyce Owaka, Rui Feng, Josef Simon Concha, Basil Patel, Emily Hejazi, Caitlin Cornwall, Scott Constantine, Nancy Dgetluck, Barbara White

Institutions: Philadelphia VA Medical Center, University of Pennsylvania, Corbus Pharmaceuticals (United States)

Language: English

Topic: Inflammatory Myopathies and Dermatomyositis

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, Pfizer, Sanofi, Italfarmaco, Medac, Genentech

OpenAlex ID: W2951466220

Cites:

Cited by: 4

Related to: 10